5.6123
전일 마감가:
$5.74
열려 있는:
$5.82
하루 거래량:
653.36K
Relative Volume:
0.24
시가총액:
$630.46M
수익:
$1.89B
순이익/손실:
$-496.52M
주가수익비율:
-1.1791
EPS:
-4.7598
순현금흐름:
$1.40M
1주 성능:
+3.63%
1개월 성능:
+33.10%
6개월 성능:
+35.35%
1년 성능:
-51.74%
Evolent Health Inc Stock (EVH) Company Profile
명칭
Evolent Health Inc
전화
571-389-6000
주소
1812 NORTH MOORE ST, SUITE 1705, ARLINGTON
Compare EVH vs VEEV, BTSG, TEM, HQY, HNGE
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
|
EVH
Evolent Health Inc
|
5.605 | 642.27M | 1.89B | -496.52M | 1.40M | -4.7598 |
|
VEEV
Veeva Systems Inc
|
194.09 | 31.31B | 3.32B | 941.65M | 1.64B | 5.6161 |
|
BTSG
Brightspring Health Services Inc
|
69.71 | 13.55B | 13.65B | 169.86M | 412.12M | 1.0758 |
|
TEM
Tempus Ai Inc
|
59.31 | 10.82B | 1.36B | -302.91M | -219.93M | -1.7182 |
|
HQY
Healthequity Inc
|
97.33 | 7.97B | 1.34B | 230.70M | 440.96M | 2.6695 |
|
HNGE
Hinge Health Inc
|
88.78 | 6.50B | 646.34M | -512.40M | 202.76M | -6.6871 |
Evolent Health Inc Stock (EVH) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-02-25 | 다운그레이드 | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2025-11-13 | 개시 | BMO Capital Markets | Outperform |
| 2025-11-13 | 업그레이드 | Stephens | Equal-Weight → Overweight |
| 2025-01-10 | 개시 | Needham | Buy |
| 2024-12-03 | 재확인 | BTIG Research | Buy |
| 2024-11-08 | 다운그레이드 | Stephens | Overweight → Equal-Weight |
| 2024-10-11 | 개시 | KeyBanc Capital Markets | Overweight |
| 2024-08-09 | 업그레이드 | Truist | Hold → Buy |
| 2024-04-22 | 개시 | Citigroup | Buy |
| 2024-03-01 | 개시 | Oppenheimer | Outperform |
| 2024-01-03 | 개시 | Barclays | Overweight |
| 2023-12-06 | 개시 | JMP Securities | Mkt Outperform |
| 2023-10-16 | 개시 | UBS | Buy |
| 2023-04-12 | 개시 | Stephens | Overweight |
| 2022-11-01 | 개시 | Truist | Hold |
| 2022-07-29 | 개시 | RBC Capital Mkts | Outperform |
| 2022-03-30 | 개시 | Guggenheim | Buy |
| 2021-11-18 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2021-04-29 | 재개 | JP Morgan | Neutral |
| 2021-01-07 | 개시 | BTIG Research | Buy |
| 2020-07-06 | 다운그레이드 | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2020-06-05 | 다운그레이드 | Goldman | Buy → Neutral |
| 2020-06-02 | 다운그레이드 | Cantor Fitzgerald | Overweight → Neutral |
| 2018-10-05 | 재개 | Leerink Partners | Outperform |
| 2018-06-04 | 개시 | Piper Jaffray | Overweight |
| 2018-04-24 | 재개 | JP Morgan | Neutral |
| 2017-09-20 | 개시 | KeyBanc Capital Mkts | Overweight |
| 2017-06-02 | 개시 | Robert W. Baird | Outperform |
| 2017-03-14 | 개시 | Oppenheimer | Outperform |
| 2017-01-13 | 업그레이드 | Wells Fargo | Market Perform → Outperform |
| 2016-10-28 | 재개 | JP Morgan | Overweight |
| 2016-08-05 | 재확인 | FBR Capital | Outperform |
| 2016-07-26 | 개시 | Jefferies | Buy |
| 2016-07-13 | 재확인 | FBR Capital | Outperform |
| 2016-03-29 | 개시 | FBR Capital | Outperform |
| 2016-01-06 | 개시 | Canaccord Genuity | Buy |
| 2015-06-30 | 개시 | Goldman | Buy |
| 2015-06-30 | 개시 | JP Morgan | Overweight |
| 2015-06-30 | 개시 | Leerink Partners | Outperform |
| 2015-06-30 | 개시 | Sun Trust Rbsn Humphrey | Buy |
모두보기
Evolent Health Inc 주식(EVH)의 최신 뉴스
Truist cuts Evolent Health stock rating on Medicaid headwinds By Investing.com - Investing.com South Africa
Truist cuts Evolent Health stock rating on Medicaid headwinds - Investing.com
Strength Seen in Evolent Health (EVH): Can Its 9.5% Jump Turn into More Strength? - Yahoo Finance
EVH Stock On Track To Open At Record Low – Here’s Why Keybanc Turned Cautious - Stocktwits
Enterprise value to EBIT forward of Evolent Health Inc Class A – FWB:9EH - TradingView
Price to sales forward of Evolent Health, Inc – NYSE:EVH - TradingView
Price to sales forward of Evolent Health Inc Class A – FWB:9EH - TradingView
Price to earnings forward of Evolent Health, Inc – NYSE:EVH - TradingView
Evolent Health Inc (EVH) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Evolent Health quarterly loss narrows, shares react to value-based care focus - AD HOC NEWS
Discipline and Rules-Based Execution in EVH Response - Stock Traders Daily
Evolent Health Inc Class A Actuals & Estimates (NYSE:EVH) - TradingView
EVH Forecast — Price Target — Prediction for 2027 - TradingView
Citigroup Maintains Evolent Health (EVH) Buy Recommendation - MSN
Evolent Health Inc (EVH) Institutional Confidence - TradingKey
Evolent Health Inc (EVH) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Evolent Health Inc (EVH) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Evolent Health Inc (EVH) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Evolent Health Inc (EVH) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Evolent Health Inc (EVH) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Evolent Health Inc (EVH) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Evolent Health Inc (EVH) Valuation: PE, PB & Fair Value Analysis - TradingKey
Evolent Health Leads Healthcare Technology Sector Focus - Kalkine Media
Q1 2026 Earnings Season Results for Healthcare Technology for Providers StocksNews and Statistics - IndexBox
Q1 Earnings Outperformers: Evolent Health (NYSE:EVH) And The Rest Of The Healthcare Technology for Providers Stocks - Yahoo Finance
Truist Financial Maintains Evolent Health(EVH.US) With Buy Rating, Announces Target Price $7 - Moomoo
Evolent Health | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plansmoomoo - Moomoo
Director Toyin Ajayi granted 41,096 RSUs at Evolent Health (EVH) - Stock Titan
Evolent Health (EVH) director Russell Glass receives 41,096 restricted stock units - Stock Titan
Evolent Health (EVH) director receives 41,096 restricted stock units grant - Stock Titan
[Form 4] Evolent Health, Inc. Insider Trading Activity - Stock Titan
Evolent Health (EVH) director receives 41,096 restricted stock units in equity grant - Stock Titan
Evolent Health (EVH) director Kim Keck granted 41,096 restricted stock units - Stock Titan
Evolent Health (EVH) director receives 41,096 restricted stock units award - Stock Titan
Director at Evolent Health (EVH) receives 41,096-share RSU grant - Stock Titan
Equity grant lifts Evolent (NYSE: EVH) director Barbarosh holdings - Stock Titan
Evolent Health | 4: Statement of changes in beneficial ownership of securities-Director Ajayi Toyin - Moomoo
Evolent Health Inc stock (US30050B1017): valuation metrics in focus after recent share price recover - AD HOC NEWS
Evolent Health Shareholders Approve Proposals at 2026 Meeting - The Globe and Mail
Evolent Health (EVH) holders back board, auditor and pay plan at 2026 meeting - Stock Titan
Evolent To Release Fourth Quarter 2024 Financial Results on Thursday, February 20, 2025 - Quantisnow
3 Healthcare Stocks We Approach with Caution - Yahoo Finance
3 Reasons EVH is Risky and 1 Stock to Buy Instead - Yahoo Finance
EVHEvolent Health Inc Stock Price and Quote - Finviz
Evolent Health(EVH) Stock Options Chain | Quotes & News - Moomoo
Evolent Health Q1 earnings call highlights - MSN
EVH Stock Price Prediction 2025-2026 | Evolent Health Inc Forecast - 24/7 Wall St.
Evolent Health : EVH - 24/7 Wall St.
Analysts’ Top Healthcare Picks: ProMIS Neurosciences (PMN), Evolent Health (EVH) - The Globe and Mail
WATER ISLAND CREDIT OPPORTUNITIES FUND's Evolent Health Inc(EVH) Holding History - GuruFocus
Evolent Health to Participate in Upcoming Conferences - GuruFocus
Evolent Health Inc (EVH) 재무 분석
매출
순이익
현금흐름
주당 순 이익
자본화:
|
볼륨(24시간):